Ela was appointed Vice President, Venture Capital Incentivized Programs, in 2021. She oversees all direct and indirect VC incentivized programs, manages the general partner educational program, and supports the federal government’s initiative to increase the availability of venture capital for promising start-ups.
Ela joined BDC Capital in 2007. She spent nine years as an investor in healthcare and life sciences companies before becoming Program Director in the Market Development Team, where she oversaw the development and launch of new initiatives for Canadian funds.
Ela’s professional background includes more than 20 years of management, entrepreneurial and consulting experience in the biopharmaceutical and related industries. She has held senior management responsibilities in drug and medical device development, as well as key involvement in product acquisition and M&A activities. She was Chief Operating Officer at an international biotech firm and has served in executive roles related to clinical, regulatory affairs and product strategy for various public and private companies. She was also Senior Vice President of Scientific Affairs for Technilab Pharma during the company’s successful IPO.
A Class 17 Kauffman Fellow, Ela is an advisor and guest lecturer with several organizations and universities. She holds a Bachelor of Science in Chemistry from the University of Western Ontario, a Master of Science in Pharmacology from the University of Toronto and an MBA in Bio-Industries from the Université du Québec à Montréal.
BDC Capital Team
Experienced. Knowledgeable. Capitalized. Connected.
At BDC Venture Capital, we are a team of dedicated, seasoned investment professionals, who bring our investee companies the benefit of decades of experience in the space. Each of our team members has been chosen for their in-depth knowledge and industry experience in sales, marketing, business development, production and R&D. It’s a team our investee companies and investment partners can trust and count on.
Contact our BDC Venture Capital team to learn more about investment opportunities for your company.